Tessa Therapeutics Funding: $200M Raised, Series A (2022)
Tessa Therapeutics is based in Singapore, Singapore. It has raised $200M in total funding. Latest round: Series A.
Tessa Therapeutics funding overview
Tessa Therapeutics is based in Singapore, Singapore. Tessa Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Tessa Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Polaris Partners, Temasek, Brandon Capital Partners, EQT Life Sciences, INKEF Capital, Mission BioCapital and 4 others. 10 distinct backers are named across the disclosed rounds.
Tessa Therapeutics at a glance
Total raised
$200M
Latest round
Series A
Latest round date
June 2022
Headquarters
Singapore, Singapore
Notable investors
Polaris Partners, Temasek, Brandon Capital Partners, EQT Life Sciences, INKEF Capital, Mission BioCapital, Sanofi Ventures, EDBI
Frequently asked about Tessa Therapeutics funding
How much has Tessa Therapeutics raised?
Tessa Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Tessa Therapeutics?
Polaris Partners, Temasek, Brandon Capital Partners, EQT Life Sciences, INKEF Capital, Mission BioCapital are named among the investors backing Tessa Therapeutics.
What was the latest Tessa Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2022.
Where is Tessa Therapeutics based?
Tessa Therapeutics is based in Singapore, Singapore.
When did Tessa Therapeutics last raise?
The last disclosed Tessa Therapeutics round closed in June 2022 at Series A.
We update the Tessa Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Singapore and their backers are listed below.
